MERIT TrialMulti-center ESG Randomized Interventional Trial for the treatment of obesity

March 15, 2019

Multi-center ESG Randomized Interventional Trial (MERIT-Trial)

  • Clinical Trial Information

    Trial Contact: Ford, Elizabeth; Tran, Helen

    Trial Phone: 321.843.5023 ; 321.841.3683

  • IRB No: 18.052.04

    Protocol Abbrev: MERIT

    Principal Investigator: Andre Fernandes Teixeira, MD

    Age Group: Adult

    Treatment: Endoscopic Sleeve Gastroplasty (ESG)

    Therapies Involved: Procedural

    ClinicalTrials.gov ID: NCT03406975

  • Objective

    Endoscopic Sleeve Gastroplasty (ESG) is an endoscopic minimally-invasive weight loss procedure, where a commercially available, FDA approved suturing device (Overstitch™) is used to reduce the stomach volume by 80% through the creation of sleeve.

  • Key Eligibility

    Age 21-65
    BMI ≥ 30 and ≤40 kg/m²